Author

Robert A Scott

GlaxoSmithKline (United Kingdom)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:GWAS / association mapping· 2 Assay:GWAS summary statistics· 2 Organism:human· 2 Approach:statistical model· 2

Frequent Co-Authors

Abdonas Tamosiunas· 1 shared Adelaida Sánchez-Gálvez· 1 shared Albert HenryiD· 1 shared Albert Hofman DiD· 1 shared Aliki‐Eleni FarmakiiD· 1 shared Allan LinnebergiD· 1 shared Amand Floriaan SchmidtiD· 1 shared Andrew N NicolaidesiD· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Abdonas Tamosiunas

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pleiotropic effects of heterozygosity for the SERPINA1 Z allele in the UK Biobank

Katherine A. Fawcett, Kijoung S Song, Guoqing Qian, Aliki‐Eleni Farmaki, Richard J. Packer, Catherine John, Nick R. G. Shrine, Raquel Granell, Susan M. Ring, Nicholas John Timpson, Laura M. Yerges-Armstrong, Richard Eastell, Louise V. Wain, Robert A Scott, Martin D. Tobin, Ian P. Hall

This study investigates the pleiotropic effects of SERPINA1 Z allele heterozygosity on various phenotypes using UK Biobank data, finding associations with height, gall bladder disease, heart disease, and lung function.

ERJ Open Research · Mar 18, 2021Peer-reviewedGenetic & Genomic Medicine

Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9

Amand Floriaan Schmidt, Michael Vaclav Holmes, David Preiss, Daniel I. Swerdlow, Spiros Denaxas, Ghazaleh Fatemifar, Rupert Faraway, Chris Finan, R Thomas Lumbers, Albert Henry, Dennis Valentine, Zammy Fairhurst-Hunter, Fernando Pires Hartwig, Bernardo Lessa Horta, Elina Hyppönen, , Albert Hofman D

The paper analyzes genetic variants at the PCSK9 locus to assess their phenotypic effects on lipid levels and disease outcomes, finding concordance with PCSK9 inhibitor trials for myocardial infarction but discordance for type 2 diabetes.

BMC Cardiovascular Disorders · Oct 29, 2019Peer-reviewedGenetics